Feb 01, 2019 - MRK earnings call for the period ending December 31, 2018.
Feb 01, 2019 - Merck & Co Inc. (NYSE:MRK) Q4 2018 Earnings Conference Call February 01, 2019 08:00 AM ET Company Participants Teri Loxam - IR Ken Frazier - Chairman and CEO Rob Davis - CFO Roger Perlmutter - Pre
Feb 01, 2019 - Merck (MRK) beats estimates for earnings as well as sales in fourth-quarter 2018. Stock is up in pre-market trading.
Jan 31, 2019 - Skyworks (SWKS) is benefiting from its portfolio strength, particularly in the 5G applications and IoT market.
Jan 30, 2019 - Roche (RHHBY) discontinues two phase III studies evaluating its anti-beta-amyloid molecule, crenezumab in people with early sporadic Alzheimer's disease.
Jan 30, 2019 - Israeli scientists claim they have a cure for cancer. Investors' response? The proof is in the pudding.
Jan 29, 2019 - Merck (MRK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Jan 25, 2019 - BMO Capital Markets issues rating change for MRK
Jan 25, 2019 - J&J (JNJ) and Bristol-Myers (BMY) kick off earnings for pharma sector. Lilly (LLY) and AbbVie (ABBV) announce failure of late-stage studies.
Jan 25, 2019 - Amgen (AMGN) along with partner Allergan reports upbeat top-line data from a phase I/III study on ABP 798, a biosimilar candidate of Roche???s Rituxan. The program achieves the primary endpoint.